Blood cancers, Polycythaemia, Thrombocythaemia
Results
Phase 3
This trial compared a pegylated interferon with hydroxyurea. It was for polycythaemia vera and essential thrombocythaemia.
The trial was supported by Cancer Research UK. It was open for people to join between 2011 and 2016. The research team published the results in 2022.
Recruitment start: 1 September 2011
Recruitment end: 30 June 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Claire Harrison
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Guy's and St Thomas' NHS Foundation Trust
Mario Negri (IRCCS)
Myeloproliferative Disorders Research Consortium (USA)
NIHR Clinical Research Network: Cancer
Roche
This is Cancer Research UK trial number CRUK/11/048.
Last reviewed: 29 Nov 2022
CRUK internal database number: 8124
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
